iRhythm Technologies Inc Stock News

SeaSpine (NASDAQ:SPNE) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings,

Even before Google's Fitbit acquisition, Alphabet already has a health wearable. The Verily Study Watch has now received FDA clearance to monitor AFib...

Gainers • Repro-Med Systems, Inc. (NASDAQ:KRMD) stock rose 4.7% to $6.53 during Wednesday's regular session. • iRhythm Technologies, Inc. (NASDAQ:IRTC) shares...

BidaskClub upgraded shares of Irhythm Technologies (NASDAQ:IRTC) from a sell rating to a hold rating in a research note issued to investors on Saturday, BidAskClub reports. Several other brokerages ha

Irhythm Technologies Inc (NASDAQ:IRTC) CEO Kevin M. King sold 39,791 shares of Irhythm Technologies stock in a transaction dated Tuesday, January 14th. The stock was sold at an average price of $80.00

Irhythm Technologies Inc (NASDAQ:IRTC) CFO Matthew C. Garrett sold 4,954 shares of the business’s stock in a transaction dated Tuesday, January 14th. The stock was sold at an average price of $80.00

Brokerages expect Irhythm Technologies Inc (NASDAQ:IRTC) to announce $58.75 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for

Shares of Irhythm Technologies Inc (NASDAQ:IRTC) have been given an average recommendation of “Buy” by the fourteen brokerages that are covering the stock, MarketBeat reports. One research analyst

BidaskClub upgraded shares of Irhythm Technologies (NASDAQ:IRTC) from a strong sell rating to a sell rating in a report published on Saturday, BidAskClub reports. Several other equities research analy

Irhythm Technologies Inc (NASDAQ:IRTC) – Investment analysts at SunTrust Banks issued their FY2019 earnings per share estimates for Irhythm Technologies in a report issued on Tuesday, January 7th. S

Equities researchers at William Blair began coverage on shares of Irhythm Technologies (NASDAQ:IRTC) in a research note issued on Thursday, The Fly reports. The firm set an “outperform” rating on

Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Neutral rating and $27 (6% upside) price target at Bank of America.Aurinia Pharmaceuticals (AUP CN) initiated with Buy rating and C$35.26 (32% upside

Equities research analysts at SunTrust Banks initiated coverage on shares of Irhythm Technologies (NASDAQ:IRTC) in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy”

Global Kinetics Pty Ltd., a digital health company focused on the development and commercialization of the Personal KinetiGraph® (PKG®), the first FDA-cleared and CE-marked platform for the object

SAN FRANCISCO, Dec. 30, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.